Study of peanut allergy therapy shows 85 percent success

A new therapy for peanut allergy has been successful in 85 per cent of children who took part in a trial funded by the MRC-NIHR Efficacy and Mechanism Evaluation (EME) Programme.  The trial is the first EME project to be published with the results appearing in The Lancet today.The research, conducted by researchers at...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news